Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 572,214 shares at $56.90 ($32.7M) on 2025-06-16, disclosed to the SEC on 2025-06-17.
Scheduled sale ($32.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.48 | 90,672 | $5.0M | 15.4% |
| 2 | $56.35 | 2,792 | $157K | 0.5% |
| 3 | $56.35 | 2,792 | $157K | 0.5% |
| 4 | $56.39 | 90,624 | $5.1M | 15.6% |
| 5 | $56.39 | 90,624 | $5.1M | 15.6% |
| 6 | $56.44 | 40,120 |
| $2.3M |
| 6.9% |
| 7 | $56.44 | 40,120 | $2.3M | 6.9% |
| 8 | $56.90 | 7,414 | $422K | 1.3% |
| 9 | $56.90 | 7,414 | $422K | 1.3% |
| 10 | $56.92 | 17,710 | $1.0M | 3.1% |
| 11 | $56.92 | 17,710 | $1.0M | 3.1% |
| 12 | $58.61 | 17,001 | $996K | 3.1% |
| 13 | $58.61 | 17,001 | $996K | 3.1% |
| 14 | $58.50 | 15,945 | $933K | 2.9% |
| 15 | $58.50 | 15,945 | $933K | 2.9% |
| 16 | $59.45 | 49,165 | $2.9M | 8.9% |
| 17 | $59.45 | 49,165 | $2.9M | 8.9% |
| Total | $57.07 avg | 572,214 | $32.7M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |